Back

Cardiac death should be the primary endpoint for revascularization trials and meta-analyses

European Heart Journal

21 September 2021
Organised by: Logo
Read full article
ESC Journals Interventional Cardiology

Contributors

Harvey D White
Harvey D White

Author

Te Whatu Ora Health New Zealand Auckland , New Zealand

You may be interested in
thumbnail
Congress Presentation
Coronary revascularization for patients with heart failure and coronary artery disease: a systematic review and meta-analysis of randomized trials
22 May 2023
thumbnail
Congress Presentation
Meaningful endpoints in cardiovascular outcome trials.
27 August 2022
thumbnail
Webinar
Percutaneous interventions in patients with coronary artery disease and specific clinical conditions - IC Core Curriculum 6
9 November 2022
thumbnail
Congress Presentation
Ten-year all-cause death after percutaneous or surgical revascularization for men and women with multivessel or left main coronary artery disease: insights from the SYNTAX extended survival study
30 August 2020

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources